Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort
Margaret Cocks(Johns Hopkins Hospital), George J. Netto(University of Pennsylvania), Mark W. Ball(Johns Hopkins University), Alan K. Meeker(Johns Hopkins University), Arthur L. Burnett(Johns Hopkins University), Alcides Chaux(Johns Hopkins University), Bernardo F. P. Ricardo(Johns Hopkins Hospital), Trinity J. Bivalacqua(University of Pennsylvania), María Del Carmen Rodríguez(Johns Hopkins Hospital), Stephania Martins Bezerra, Diana Taheri(Harvard University), Rajni Sharma(Central University of Punjab)
Cited by 82
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k